This image has an empty alt attribute; its file name is Immagine-WhatsApp-2023-12-04-ore-10.44.45_6c76537b-1024x695.jpg

The NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka (Zambia). NeuroSolve is a four-year project funded by EDCTP3, lead by an African-European research consortium involves the University of Dar es Salaam (UDSM – Tanzania), Sokoine University of Agriculture (SUA – Tanzania), University of Zambia (UNZA – Zambia), Revolution Worldwide Srl – Impresa Sociale (R-EvoWW – Italy) and Universiteit Ghent (UGent – Belgium).

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

HANTAAN-VAX-EU-Proposal submitted under the Horizon Europe call for a multiplatform vaccine against Hantaan virus

Hantaan virus (HTNV) is one of the main causes of haemorrhagic fever with renal syndrome (HFRS), a severe disease affecting endemic regions across Asia, with growing concern over its geographical

R-Evolution Worldwide visits accredited genomics and clinical trial facilities at Ifakara Health Institute

Tanzania, Morogoro Region – Ifakara On the occasion of the NeuroSolve 2026 Annual Meeting, we had the privilege of visiting the local facilities where critical research and diagnostic work are

HIV-associated multimorbidity: a trial of a “screen and link” strategy post hospital admission to improve outcomes in adults in sub-Saharan Africa

Our organisation has submitted a project proposal titled MULTILINK-HIV under the European funding call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage: Global collaboration action towards better prevention, treatment and clinical management of HIV coinfections or co-morbidities